Добро пожаловать в клуб

Показать / Спрятать  Домой  Новости Статьи Файлы Форум Web ссылки F.A.Q. Логобург    Показать / Спрятать

       
Поиск   
Главное меню
ДомойНовостиСтатьиПостановка звуковФайлыДефектологияКнижный мирФорумСловарьРассылкаКаталог ссылокРейтинг пользователейЧаВо(FAQ)КонкурсWeb магазинШкольникамКарта сайта

Поздравляем!
Поздравляем нового Логобуржца Акулина со вступлением в клуб!

Реклама

КНИЖНЫЙ МИР

Oral Riboflavin versus Propranolol in the Prophylaxis of Migraine   Natasha Nambiar

Oral Riboflavin versus Propranolol in the Prophylaxis of Migraine

2012 год.
LAP Lambert Academic Publishing
Migraine is a chronic, often debilitating disease that affects 12% of the general population. The effective management of migraine involves the active treatment of acute episodes combined with non-pharmacological and pharmacological treatments for the prevention of migraine. The treatment of migraine with the reference prophylactic beta blocker propranolol (80-240mg/day) is limited by side effects and lack of tolerability. Riboflavin (vitamin B2) is the precursor of flavin mononucleotide and flavin adenine dinucleotide which are involved in mitochondrial transport chain. The use of riboflavin in migraine treatment is based on the hypothesis of a deficient mitochondrial energy reserve as a causal factor in migraine pathogenesis and on the findings of its safety and effectiveness at high doses (100-200mg/day) in the treatment of migraine like headaches in classic mitochondriopathies. Till date there have been four studies (two open trials and two randomized controlled) using high dose...
 
- Генерация страницы: 0.04 секунд -